Introduction:
The pharmaceutical industry in Mexico has experienced significant growth in recent years, driven by factors such as increasing healthcare expenditures, a growing population, and the rise in chronic diseases. According to recent data, the Mexican pharmaceutical market is valued at over $20 billion, with a strong focus on generic drugs. In this report, we will outline the top 10 private label and store brand generic drug suppliers in Mexico.
Top 10 Private Label & Store Brand Generic Drug Suppliers in Mexico:
1. Laboratorios PiSA
– Market share: 15%
– Laboratorios PiSA is a leading supplier of generic drugs in Mexico, known for its high-quality products and competitive prices. With a market share of 15%, the company has established itself as a key player in the industry.
2. Genomma Lab
– Market share: 10%
– Genomma Lab is another major player in the Mexican pharmaceutical market, specializing in over-the-counter medications and personal care products. The company holds a 10% market share and continues to expand its product portfolio.
3. Rimsa
– Production volume: 500,000 units per month
– Rimsa is a well-known manufacturer of generic drugs in Mexico, producing a wide range of medications for various therapeutic areas. With a production volume of 500,000 units per month, the company is a key supplier to the local market.
4. Chinoin
– Exports: $50 million annually
– Chinoin is a leading exporter of generic drugs from Mexico, with annual exports totaling $50 million. The company’s products are distributed to numerous countries around the world, contributing to its strong market presence.
5. Senosiain
– Market share: 8%
– Senosiain is a prominent supplier of private label and store brand generic drugs in Mexico, holding an 8% market share. The company focuses on quality and innovation, catering to the diverse needs of healthcare providers and consumers.
6. Silanes
– Trade value: $100 million
– Silanes is a key player in the Mexican pharmaceutical industry, with a trade value of $100 million. The company’s commitment to research and development has enabled it to introduce new and effective generic drugs to the market.
7. Italchem
– Market share: 6%
– Italchem is a major manufacturer of private label and store brand generic drugs in Mexico, capturing a 6% market share. The company’s extensive product portfolio and strong distribution network have contributed to its success in the industry.
8. Productos Farmaceuticos Collins
– Production volume: 300,000 units per month
– Productos Farmaceuticos Collins is a leading producer of generic drugs in Mexico, with a production volume of 300,000 units per month. The company’s state-of-the-art manufacturing facilities ensure the quality and consistency of its products.
9. Probiomed
– Exports: $40 million annually
– Probiomed is a well-established exporter of generic drugs from Mexico, with annual exports amounting to $40 million. The company’s international presence and adherence to global quality standards have made it a trusted supplier worldwide.
10. Sanfer
– Market share: 5%
– Sanfer is a reputable supplier of private label and store brand generic drugs in Mexico, holding a 5% market share. The company’s focus on customer satisfaction and continuous improvement has helped it maintain a strong position in the market.
Insights:
Looking ahead, the Mexican pharmaceutical industry is poised for further growth, driven by factors such as increasing demand for generic drugs, technological advancements, and government initiatives to improve healthcare access. According to projections, the market is expected to reach $25 billion by 2025, with private label and store brand generic drug suppliers playing a crucial role in meeting the evolving needs of consumers. As competition intensifies, companies will need to focus on innovation, regulatory compliance, and strategic partnerships to maintain their competitive edge in the market.
Related Analysis: View Previous Industry Report
